Результаты поиска - Faramarz Ismail‐Beigi
- Отображение 1 - 20 результаты of 49
- Перейти на следующую страницу
-
1
Clinical Implications of the ACCORD Trial по Saul Genuth, Faramarz Ismail‐Beigi
Опубликовано 2011Revisão -
2
Mechanism of Thyroid Calorigenesis: Role of Active Sodium Transport по Faramarz Ismail‐Beigi, Isidore S. Edelman
Опубликовано 1970Artigo -
3
-
4
-
5
The Mechanism of the Calorigenic Action of Thyroid Hormone по Faramarz Ismail‐Beigi, Isidore S. Edelman
Опубликовано 1971Artigo -
6
Thyroidal regulation of rat renal and hepatic Na,K-ATPase gene expression. по Gregory Gick, Faramarz Ismail‐Beigi, I. S. Edelman
Опубликовано 1988Artigo -
7
<p>Glucocorticoid-Induced Fatty Liver Disease</p> по Leili Rahimi, Aman Rajpal, Faramarz Ismail‐Beigi
Опубликовано 2020Revisão -
8
-
9
-
10
-
11
-
12
Regulation of glut1 mRNA by Hypoxia-inducible Factor-1 по Changhu Chen, Nabendu Pore, Alireza Behrooz, Faramarz Ismail‐Beigi, Amit Maity
Опубликовано 2001Artigo -
13
-
14
-
15
-
16
-
17
The effect of sodium-glucose co-transporter-2 (SGLT2) inhibitors on blood interleukin-6 concentration: a systematic review and meta-analysis of randomized controlled trials по Sepehr Gohari, Faramarz Ismail‐Beigi, Mahsa Mahjani, Saeed Ghobadi, Alireza Jafari, Hassan Ahangar, Sheida Gohari
Опубликовано 2023Revisão -
18
Effect of Empagliflozin on Liver Steatosis and Fibrosis in Patients With Non-Alcoholic Fatty Liver Disease Without Diabetes: A Randomized, Double-Blind, Placebo-Controlled Trial по Hoda Taheri, Mojtaba Malek, Faramarz Ismail‐Beigi, Farhad Zamani, Masoudreza Sohrabi, Mohammad Reza Babaei, Mohammad E. Khamseh
Опубликовано 2020Artigo -
19
-
20
Инструменты поиска:
Связанные темы
Endocrinology
Medicine
Internal medicine
Diabetes mellitus
Type 2 diabetes
Insulin
Biology
Chemistry
Intensive care medicine
Biochemistry
Insulin resistance
Randomized controlled trial
Confidence interval
Disease
Glycemic
Gene
Alternative medicine
Hazard ratio
Hypoglycemia
Organic chemistry
Pathology
Placebo
Cardiology
Cell biology
Environmental health
Kidney disease
Population
Diabetic retinopathy
Empagliflozin
Engineering